P
INSM icon

&Partners’s Insmed INSM Stock Holding History

&Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$847K Sell
7,952
-246
-3% -$29.8K ﹤0.01% 1517
2026
Q1 		$1.34M Buy
8,198
+939
+13% +$144K 0.01% 1134
2025
Q4 		$1.26M Buy
7,259
+1,213
+20% +$221K 0.01% 1099
2025
Q3 		$871K Buy
6,046
+330
+6% +$40.4K 0.01% 1155
2025
Q2 		$575K Buy
5,716
+406
+8% +$31K ﹤0.01% 1284
2025
Q1 		$414K Buy
5,310
+377
+8% +$28.8K ﹤0.01% 1228
2024
Q4 		$341K Buy
4,933
+31
+0.6% +$2.23K ﹤0.01% 1268
2024
Q3 		$358K Buy
4,902
+425
+9% +$31.4K 0.01% 1018
2024
Q2 		$300K Buy
+4,477
New +$174K 0.01% 716

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

&Partners's INSM Position: Q2 2026 in Review

&Partners reduced its Insmed (INSM) stake by 3% in Q2 2026, selling an estimated $29.8K and leaving 7,952 shares worth $847K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

&Partners first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • &Partners held 7,952 shares of Insmed worth $847K as of Q2 2026.
  • &Partners sold 246 Insmed shares in Q2 2026, an estimated $29.8K.
  • Insmed made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1517 holding.
  • &Partners first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Insmed position peaked at $1.34M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.